IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel ...

Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's patent rights in nerve-stimulation technology. April 4, 2024 FTC seeks more ...

Axonics recently announced it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) to market the Axonics F15 recharge-free sacral neuromodulation (SNM) system for ...

Boston Scientific Corporation BSX recently closed the acquisition of Axonics, Inc., a medical technology company focused on the development and commercialization of differentiated devices to treat ...